Inmune Bio, Inc. Common Stock Shares Outstanding

Quick Answer

Inmune Bio, Inc. reported Common Stock Shares Outstanding of 26.59 million shares for the year ending 2025.

  • Inmune Bio, Inc. showed an increase of +19.3% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Inmune Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Inmune Bio, Inc.'s Common Stock Shares Outstanding has grown by 219.6%.
  • Historical annual values: Fiscal year 2025: 26.59 million shares | Fiscal year 2024: 22.28 million shares | Fiscal year 2023: 17.95 million shares | Fiscal year 2022: 17.95 million shares | Fiscal year 2021: 17.84 million shares | Fiscal year 2020: 13.48 million shares | Fiscal year 2019: 10.77 million shares | Fiscal year 2018: 8.72 million shares | Fiscal year 2017: 8.32 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: